References
- Tzeng AC, Cheng JF, Fryczynski H, et al. A study of thyrotrophin-releasing hormone for the treatment of spinal muscular atrophy: a preliminary report. Am J Phys Med Rehabil. 2000;79:435–440.
- Tuttle AH, Tohyama S, Ramsay T, et al. Increasing placebo responses over time in U.S. clinical trials of neuropathic pain. Pain. 2015;156:2616–2626.
- Avins AL, Cherkin DC, Sherman KJ, et al. Should we reconsider the routine use of placebo controls in clinical research? Trials. 2012;13:44.
- Sackett DL, Rosenberg WM, Gray JA, et al. Evidence based medicine: what it is and what it isn’t. 1996. Clin Orthop Relat Res. 2007;455:3–5.
- Cook DJ, Guyatt GH, Laupacis A, et al. Rules of evidence and clinical recommendations on the use of antithrombotic agents. Chest. 1992;102:305S–11S.
- Bach JR. The Duchenne de Boulogne-Meryon controversy and pseudohypertrophic muscular dystrophy. J Hist Med Allied Sci. 2000;55:158–178.
- Wootton D. Bad medicine. Oxford University Press; 2007.
- Bach JR, Chiou M. Limitations of evidence-based medicine. Rev Port Pneumol. 2016;22:4–5.
- Rose L, Adhikari NK, Leasa D, et al. Cough augmentation techniques for extubation or weaning critically ill patients from mechanical ventilation. Cochrane Database Syst Rev. 2017;1. Oxford University Press. DOI:10.1002/14651858.CD011833.pub2
- Morrow B, Zampoli M, van Aswegen H, et al. Mechanical insufflation-exsufflation for people with neuromuscular disorders. Cochrane Database Syst Rev. 2013;12:CD011833. DOI:10.1002/14651858.CD011833.pub2.
- Annane D, Orlikowski D, Chevret S. Nocturnal mechanical ventilation for chronic hypoventilation in patients with neuromuscular and chest wall disorders. Cochrane Database Syst Rev. 2014 Dec;13(12):CD001941.
- Bach JR, Gonçalves MR, Hamdani I, et al. Extubation of unweanable patients with neuromuscular weakness: a new management paradigm. Chest. 2010;137:1033–1039.
- Smith GC, Pell JP. Parachute use to prevent death and major trauma related to gravitational challenge: systematic review of randomised controlled trials. BMJ. 2003;327(7429):1459–1461.
- DiMasi JA, Grabowski HG, Hansen RW. Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ. 2016;47:20–33.
- Brill S Why medical bills are killing us. Time Magazine Special Report. 2013 Feb 20.
- Harrison D, Mehta P, van Es MA, et al. “ALS reversals”: demographics, disease characteristics, treatments, and co-morbidities. Amyotroph Lateral Scler Frontotemporal Degener. 2018;19:495–499.
- Patel S, Cuenant L, Bach JR. Respiratory management of spinal muscular atrophy. J Clin Neurol Neurosurg. 2019;2:119.
- Bach JR, DeLisa JD. An alternative view on medical care delivery: a commentary. Am J Phys Med Rehabil. 2014;93:1095–1099.